化学療法による心筋病症のがん患者の心臓再同期療法:ミニレビュー
Cinzia Valzania1, Valeria Calvi2, Valentina Schirripa3
1Department of Cardiology, IRCCS - Azienda Ospedaliero, Universitaria Di Bologna - Policlinico Di S. Orsola, Bologna, Italy.
Heart failure reviews
|September 4, 2025
まとめ
化学療法による心筋病 (CHIC) は大きな課題です 心臓再同期療法 (CRT) が有望である一方で,CHIC患者の長期的な利益を理解するには,さらなる研究が必要です.
科学分野:
- 心臓病科
- 腫瘍学
- 心臓腫瘍学
背景:
- 化学療法による心筋病症 (CHIC) は,心臓毒性がん治療による臨床上の懸念が高まっている.
- これらの治療は漸進的な心筋機能障害と心不全を引き起こす可能性があります.
- 心臓再同期療法 (CRT) の臨床試験では,CHIC患者数が不足しています.
研究 の 目的:
- CHIC患者のCRTの使用に関する現在の証拠をレビューする.
- 既存の研究の限界とさらなる研究の必要性を強調する.
- CHIC患者の管理における多学科アプローチの重要性を強調する.
主な方法:
- 遡及的,観察的,および単一の見通し試験 (MADIT-CHIC) を含む既存の文献のレビュー.
- 左心室不協和症,不律症,生存に対するCRTの影響に関するデータの分析.
- 患者の管理とCRTのタイミングにおける心臓腫瘍学の役割についての議論
主要な成果:
- CHICにおけるCRTの現在の証拠は,主に短いフォローアップで小規模で遡及的な研究から限られています.
- MADIT- CHIC試験は唯一の前向きな試験ですが,ランダム化制御試験はありません.
- CHIC患者における不協和性,不律性,生存に対するCRTの長期的な影響は完全に理解されていません.
結論:
- 選択されたCHIC患者では,CRTが有益である可能性はあるが,確固たる証拠は不足している.
- ランダム化制御試験を含むさらなる研究は,患者の選択を最適化し,長期的な結果を評価するために不可欠です.
- 効果的な治療と CRT の適時な検討には,多学科的な心臓腫瘍学のアプローチが不可欠です.
関連する概念動画
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
01:29Cardiomyopathy VI: Nursing Management
481
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460